retatrutide ly3437943 glp-1 gip glucagon triple agonist phase 2 results LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: Retatrutide 60mg | 10-Vial Kit

When reduced forms of coenzyme Q 10 (CoQ 10 H 2 ), vitamin C (ascorbate), or glutathione (GSH) reduce oxidized -tocopherol (-TO), they themselves become oxidized (ubisemiquinone, dehydroascorbate, or GSSG)

Country of Origin: USA Manufacturer/Importer/Packed By: Douglas Laboratories

J Clin Pathol (2007) 60(7):75661

The labeling still carries the full weight of warnings from both drug classes (liver risk from acetaminophen, GI/cardiovascular risk from NSAIDs)a good reminder that "OTC" doesn't mean "no risk." I'm curious what others in the regulatory space thinkis this Rx-to-OTC trend something we'll see more of globally, including in India